Litwin M, Grenda R, Jelonek A
Oddziału Dializoterapii i Transplantacji Nerek Pomnika Szpitala Centrum Zdrowia Dziecka, Warszawie.
Pol Tyg Lek. 1994;49(6-7):132-4.
Human recombinant erythropoietin has been administered to 10 children with uremic anaemia in the course of renal failure. Children have been treated with repeated hemodialyses. During a 6-month follow-up, hematocrit and hemoglobin have been 30% and 9-10 g/dL, respectively. An increase in serum uric acid with a decrease in iron levels and transferrin saturation have been noted in all children. No serious adverse reactions have been seen.
已对10名处于肾衰竭病程中的尿毒症贫血患儿给予了重组人促红细胞生成素。这些患儿接受了多次血液透析治疗。在6个月的随访期间，血细胞比容和血红蛋白分别为30%和9 - 10g/dL。所有患儿均出现血清尿酸升高，同时铁水平和转铁蛋白饱和度降低。未观察到严重不良反应。
